APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liraglutide

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Selected research

Market Analysis & Forecast

Global Liraglutide Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchLiraglutide Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Liraglutide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Liraglutide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liraglutide Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Liraglutide Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

The global Liraglutide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liraglutide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Europe market for Liraglutide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Liraglutide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liraglutide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide and AmbioPharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liraglutide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liraglutide, also provides the sales of main regions and countries. Of the upcoming market potential for Liraglutide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liraglutide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liraglutide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liraglutide sales, projected growth trends, production technology, application and end-user industry.

Liraglutide Segment by Company

HEC Pharm

Bachem

Bharat Pharmaceuticals

Kingpep Biotechnology

Shenzhen JYMed Technology

Wuxi Asiapeptide

AmbioPharm

Liraglutide Segment by Type

Pills

Liquid

Liraglutide Segment by Application

Hospital

Drug Store

Liraglutide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liraglutide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liraglutide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liraglutide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Liraglutide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Liraglutide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liraglutide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liraglutide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pills Major Manufacturers Table 3. Liquid Major Manufacturers Table 4. Global Liraglutide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Liraglutide Industry Trends Table 8. Liraglutide Industry Drivers Table 9. Liraglutide Industry Opportunities and Challenges Table 10. Liraglutide Industry Restraints Table 11. Global Liraglutide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Liraglutide Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Liraglutide Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Liraglutide Revenue Market Share by Region (2021-2026) Table 15. Global Liraglutide Revenue Market Share by Region (2027-2032) Table 16. Global Liraglutide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K MT) Table 17. Global Liraglutide Sales by Region (2021-2026) & (K MT) Table 18. Global Liraglutide Sales by Region (2027-2032) & (K MT) Table 19. Global Liraglutide Sales Market Share by Region (2021-2026) Table 20. Global Liraglutide Sales Market Share by Region (2027-2032) Table 21. Global Liraglutide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Liraglutide Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Liraglutide Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Liraglutide Sales Market Share by Manufacturers (2021-2026) Table 25. Global Liraglutide Sales Price (USD/MT) of Manufacturers (2021-2026) Table 26. Global Liraglutide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Liraglutide Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Liraglutide Manufacturers, Product Type & Application Table 29. Global Liraglutide Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Liraglutide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Liraglutide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Liraglutide Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Liraglutide Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Liraglutide Revenue Market Share by Type (2021-2026) Table 36. Global Liraglutide Revenue Market Share by Type (2027-2032) Table 37. Global Liraglutide Sales by Type 2021 VS 2025 VS 2032 (K MT) Table 38. Global Liraglutide Sales by Type (2021-2026) & (K MT) Table 39. Global Liraglutide Sales by Type (2027-2032) & (K MT) Table 40. Global Liraglutide Sales Market Share by Type (2021-2026) Table 41. Global Liraglutide Sales Market Share by Type (2027-2032) Table 42. Global Liraglutide Price by Type (2021-2026) & (USD/MT) Table 43. Global Liraglutide Price by Type (2027-2032) & (USD/MT) Table 44. Global Liraglutide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Liraglutide Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Liraglutide Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Liraglutide Revenue Market Share by Application (2021-2026) Table 48. Global Liraglutide Revenue Market Share by Application (2027-2032) Table 49. Global Liraglutide Sales by Application 2021 VS 2025 VS 2032 (K MT) Table 50. Global Liraglutide Sales by Application (2021-2026) & (K MT) Table 51. Global Liraglutide Sales by Application (2027-2032) & (K MT) Table 52. Global Liraglutide Sales Market Share by Application (2021-2026) Table 53. Global Liraglutide Sales Market Share by Application (2027-2032) Table 54. Global Liraglutide Price by Application (2021-2026) & (USD/MT) Table 55. Global Liraglutide Price by Application (2027-2032) & (USD/MT) Table 56. HEC Pharm Company Information Table 57. HEC Pharm Business Overview Table 58. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 59. HEC Pharm Liraglutide Product Portfolio Table 60. HEC Pharm Recent Development Table 61. Bachem Company Information Table 62. Bachem Business Overview Table 63. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 64. Bachem Liraglutide Product Portfolio Table 65. Bachem Recent Development Table 66. Bharat Pharmaceuticals Company Information Table 67. Bharat Pharmaceuticals Business Overview Table 68. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 69. Bharat Pharmaceuticals Liraglutide Product Portfolio Table 70. Bharat Pharmaceuticals Recent Development Table 71. Kingpep Biotechnology Company Information Table 72. Kingpep Biotechnology Business Overview Table 73. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. Kingpep Biotechnology Liraglutide Product Portfolio Table 75. Kingpep Biotechnology Recent Development Table 76. Shenzhen JYMed Technology Company Information Table 77. Shenzhen JYMed Technology Business Overview Table 78. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. Shenzhen JYMed Technology Liraglutide Product Portfolio Table 80. Shenzhen JYMed Technology Recent Development Table 81. Wuxi Asiapeptide Company Information Table 82. Wuxi Asiapeptide Business Overview Table 83. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. Wuxi Asiapeptide Liraglutide Product Portfolio Table 85. Wuxi Asiapeptide Recent Development Table 86. AmbioPharm Company Information Table 87. AmbioPharm Business Overview Table 88. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. AmbioPharm Liraglutide Product Portfolio Table 90. AmbioPharm Recent Development Table 91. North America Liraglutide Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Liraglutide Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Liraglutide Sales by Type (2021-2026) & (K MT) Table 94. North America Liraglutide Sales by Type (2027-2032) & (K MT) Table 95. North America Liraglutide Sales Price by Type (2021-2026) & (USD/MT) Table 96. North America Liraglutide Sales Price by Type (2027-2032) & (USD/MT) Table 97. North America Liraglutide Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Liraglutide Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Liraglutide Sales by Application (2021-2026) & (K MT) Table 100. North America Liraglutide Sales by Application (2027-2032) & (K MT) Table 101. North America Liraglutide Sales Price by Application (2021-2026) & (USD/MT) Table 102. North America Liraglutide Sales Price by Application (2027-2032) & (USD/MT) Table 103. North America Liraglutide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Liraglutide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Liraglutide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Liraglutide Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 107. North America Liraglutide Sales by Country (2021-2026) & (K MT) Table 108. North America Liraglutide Sales by Country (2027-2032) & (K MT) Table 109. North America Liraglutide Sales Price by Country (2021-2026) & (USD/MT) Table 110. North America Liraglutide Sales Price by Country (2027-2032) & (USD/MT) Table 111. United States Liraglutide Revenue (2021-2032) & (US$ Million) Table 112. Canada Liraglutide Revenue (2021-2032) & (US$ Million) Table 113. Mexico Liraglutide Revenue (2021-2032) & (US$ Million) Table 114. Europe Liraglutide Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Liraglutide Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Liraglutide Sales by Type (2021-2026) & (K MT) Table 117. Europe Liraglutide Sales by Type (2027-2032) & (K MT) Table 118. Europe Liraglutide Sales Price by Type (2021-2026) & (USD/MT) Table 119. Europe Liraglutide Sales Price by Type (2027-2032) & (USD/MT) Table 120. Europe Liraglutide Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Liraglutide Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Liraglutide Sales by Application (2021-2026) & (K MT) Table 123. Europe Liraglutide Sales by Application (2027-2032) & (K MT) Table 124. Europe Liraglutide Sales Price by Application (2021-2026) & (USD/MT) Table 125. Europe Liraglutide Sales Price by Application (2027-2032) & (USD/MT) Table 126. Europe Liraglutide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Liraglutide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Liraglutide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Liraglutide Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 130. Europe Liraglutide Sales by Country (2021-2026) & (K MT) Table 131. Europe Liraglutide Sales by Country (2027-2032) & (K MT) Table 132. Europe Liraglutide Sales Price by Country (2021-2026) & (USD/MT) Table 133. Europe Liraglutide Sales Price by Country (2027-2032) & (USD/MT) Table 134. Germany Liraglutide Revenue (2021-2032) & (US$ Million) Table 135. France Liraglutide Revenue (2021-2032) & (US$ Million) Table 136. U.K. Liraglutide Revenue (2021-2032) & (US$ Million) Table 137. Italy Liraglutide Revenue (2021-2032) & (US$ Million) Table 138. Russia Liraglutide Revenue (2021-2032) & (US$ Million) Table 139. Spain Liraglutide Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Liraglutide Revenue (2021-2032) & (US$ Million) Table 141. Switzerland Liraglutide Revenue (2021-2032) & (US$ Million) Table 142. Sweden Liraglutide Revenue (2021-2032) & (US$ Million) Table 143. Poland Liraglutide Revenue (2021-2032) & (US$ Million) Table 144. China Liraglutide Revenue by Type (2021-2026) & (US$ Million) Table 145. China Liraglutide Revenue by Type (2027-2032) & (US$ Million) Table 146. China Liraglutide Sales by Type (2021-2026) & (K MT) Table 147. China Liraglutide Sales by Type (2027-2032) & (K MT) Table 148. China Liraglutide Sales Price by Type (2021-2026) & (USD/MT) Table 149. China Liraglutide Sales Price by Type (2027-2032) & (USD/MT) Table 150. China Liraglutide Revenue by Application (2021-2026) & (US$ Million) Table 151. China Liraglutide Revenue by Application (2027-2032) & (US$ Million) Table 152. China Liraglutide Sales by Application (2021-2026) & (K MT) Table 153. China Liraglutide Sales by Application (2027-2032) & (K MT) Table 154. China Liraglutide Sales Price by Application (2021-2026) & (USD/MT) Table 155. China Liraglutide Sales Price by Application (2027-2032) & (USD/MT) Table 156. Asia Liraglutide Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Liraglutide Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Liraglutide Sales by Type (2021-2026) & (K MT) Table 159. Asia Liraglutide Sales by Type (2027-2032) & (K MT) Table 160. Asia Liraglutide Sales Price by Type (2021-2026) & (USD/MT) Table 161. Asia Liraglutide Sales Price by Type (2027-2032) & (USD/MT) Table 162. Asia Liraglutide Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Liraglutide Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Liraglutide Sales by Application (2021-2026) & (K MT) Table 165. Asia Liraglutide Sales by Application (2027-2032) & (K MT) Table 166. Asia Liraglutide Sales Price by Application (2021-2026) & (USD/MT) Table 167. Asia Liraglutide Sales Price by Application (2027-2032) & (USD/MT) Table 168. Asia Liraglutide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Liraglutide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Liraglutide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Liraglutide Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 172. Asia Liraglutide Sales by Country (2021-2026) & (K MT) Table 173. Asia Liraglutide Sales by Country (2027-2032) & (K MT) Table 174. Asia Liraglutide Sales Price by Country (2021-2026) & (USD/MT) Table 175. Asia Liraglutide Sales Price by Country (2027-2032) & (USD/MT) Table 176. Japan Liraglutide Revenue (2021-2032) & (US$ Million) Table 177. South Korea Liraglutide Revenue (2021-2032) & (US$ Million) Table 178. India Liraglutide Revenue (2021-2032) & (US$ Million) Table 179. Australia Liraglutide Revenue (2021-2032) & (US$ Million) Table 180. Taiwan Liraglutide Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Liraglutide Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Liraglutide Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Liraglutide Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Liraglutide Sales by Type (2021-2026) & (K MT) Table 185. SAMEA Liraglutide Sales by Type (2027-2032) & (K MT) Table 186. SAMEA Liraglutide Sales Price by Type (2021-2026) & (USD/MT) Table 187. SAMEA Liraglutide Sales Price by Type (2027-2032) & (USD/MT) Table 188. SAMEA Liraglutide Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Liraglutide Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Liraglutide Sales by Application (2021-2026) & (K MT) Table 191. SAMEA Liraglutide Sales by Application (2027-2032) & (K MT) Table 192. SAMEA Liraglutide Sales Price by Application (2021-2026) & (USD/MT) Table 193. SAMEA Liraglutide Sales Price by Application (2027-2032) & (USD/MT) Table 194. SAMEA Liraglutide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Liraglutide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Liraglutide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Liraglutide Sales by Country (2021 VS 2025 VS 2032) & (K MT) Table 198. SAMEA Liraglutide Sales by Country (2021-2026) & (K MT) Table 199. SAMEA Liraglutide Sales by Country (2027-2032) & (K MT) Table 200. SAMEA Liraglutide Sales Price by Country (2021-2026) & (USD/MT) Table 201. SAMEA Liraglutide Sales Price by Country (2027-2032) & (USD/MT) Table 202. Brazil Liraglutide Revenue (2021-2032) & (US$ Million) Table 203. Argentina Liraglutide Revenue (2021-2032) & (US$ Million) Table 204. Chile Liraglutide Revenue (2021-2032) & (US$ Million) Table 205. Colombia Liraglutide Revenue (2021-2032) & (US$ Million) Table 206. Peru Liraglutide Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Liraglutide Revenue (2021-2032) & (US$ Million) Table 208. Israel Liraglutide Revenue (2021-2032) & (US$ Million) Table 209. UAE Liraglutide Revenue (2021-2032) & (US$ Million) Table 210. Turkey Liraglutide Revenue (2021-2032) & (US$ Million) Table 211. Iran Liraglutide Revenue (2021-2032) & (US$ Million) Table 212. Egypt Liraglutide Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Liraglutide Distributors List Table 216. Liraglutide Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Liraglutide Image Figure 2. Global Liraglutide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liraglutide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pills Image Figure 5. Liquid Image Figure 6. Global Liraglutide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Liraglutide Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug Store Image Figure 10. Global Liraglutide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Liraglutide Revenue (2021-2032) & (US$ Million) Figure 12. Global Liraglutide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Liraglutide Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Liraglutide Revenue Market Share by Region (2021-2032) Figure 15. Global Liraglutide Sales (2021-2032) & (K MT) Figure 16. Global Liraglutide Sales by Region: 2021 VS 2025 VS 2032 (K MT) Figure 17. Global Liraglutide Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Liraglutide Sales YoY (2021-2032) & (K MT) Figure 19. Europe Liraglutide Sales YoY (2021-2032) & (K MT) Figure 20. China Liraglutide Sales YoY (2021-2032) & (K MT) Figure 21. Asia (Excluding China) Liraglutide Sales YoY (2021-2032) & (K MT) Figure 22. South America, Middle East and Africa Liraglutide Sales YoY (2021-2032) & (K MT) Figure 23. Global Liraglutide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Liraglutide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Liraglutide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Liraglutide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Liraglutide Revenue Market Share by Type (2021-2032) Figure 29. Global Liraglutide Sales by Type (2021 VS 2025 VS 2032) & (K MT) Figure 30. Global Liraglutide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Liraglutide Sales Market Share by Type (2021-2032) Figure 32. Global Liraglutide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Liraglutide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Liraglutide Revenue Market Share by Application (2021-2032) Figure 35. Global Liraglutide Sales by Application (2021 VS 2025 VS 2032) & (K MT) Figure 36. Global Liraglutide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Liraglutide Sales Market Share by Application (2021-2032) Figure 38. North America Liraglutide Revenue Share by Type (2021-2032) Figure 39. North America Liraglutide Sales Share by Type (2021-2032) Figure 40. North America Liraglutide Revenue Share by Application (2021-2032) Figure 41. North America Liraglutide Sales Share by Application (2021-2032) Figure 42. North America Liraglutide Revenue Share by Country (2021-2032) Figure 43. North America Liraglutide Sales Share by Country (2021-2032) Figure 44. Europe Liraglutide Revenue Share by Type (2021-2032) Figure 45. Europe Liraglutide Sales Share by Type (2021-2032) Figure 46. Europe Liraglutide Revenue Share by Application (2021-2032) Figure 47. Europe Liraglutide Sales Share by Application (2021-2032) Figure 48. Europe Liraglutide Revenue Share by Country (2021-2032) Figure 49. Europe Liraglutide Sales Share by Country (2021-2032) Figure 50. China Liraglutide Revenue Share by Type (2021-2032) Figure 51. China Liraglutide Sales Share by Type (2021-2032) Figure 52. China Liraglutide Revenue Share by Application (2021-2032) Figure 53. China Liraglutide Sales Share by Application (2021-2032) Figure 54. Asia Liraglutide Revenue Share by Type (2021-2032) Figure 55. Asia Liraglutide Sales Share by Type (2021-2032) Figure 56. Asia Liraglutide Revenue Share by Application (2021-2032) Figure 57. Asia Liraglutide Sales Share by Application (2021-2032) Figure 58. Asia Liraglutide Revenue Share by Country (2021-2032) Figure 59. Asia Liraglutide Sales Share by Country (2021-2032) Figure 60. SAMEA Liraglutide Revenue Share by Type (2021-2032) Figure 61. SAMEA Liraglutide Sales Share by Type (2021-2032) Figure 62. SAMEA Liraglutide Revenue Share by Application (2021-2032) Figure 63. SAMEA Liraglutide Sales Share by Application (2021-2032) Figure 64. SAMEA Liraglutide Revenue Share by Country (2021-2032) Figure 65. SAMEA Liraglutide Sales Share by Country (2021-2032) Figure 66. Liraglutide Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Liraglutide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Pills
  • Liquid
Applications
  • Hospital
  • Drug Store
Companies covered
  • HEC Pharm
  • Bachem
  • Bharat Pharmaceuticals
  • Kingpep Biotechnology
  • Shenzhen JYMed Technology
  • Wuxi Asiapeptide
  • AmbioPharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liraglutide Market by Type
  3. 1.2.1 Global Liraglutide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pills
  5. 1.2.3 Liquid
  6. 1.3 Liraglutide Market by Application
  7. 1.3.1 Global Liraglutide Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug Store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Liraglutide Market Dynamics
  1. 2.1 Liraglutide Industry Trends
  2. 2.2 Liraglutide Industry Drivers
  3. 2.3 Liraglutide Industry Opportunities and Challenges
  4. 2.4 Liraglutide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Liraglutide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Liraglutide Revenue by Region
  3. 3.2.1 Global Liraglutide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liraglutide Revenue by Region (2021-2026)
  5. 3.2.3 Global Liraglutide Revenue by Region (2027-2032)
  6. 3.2.4 Global Liraglutide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Liraglutide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Liraglutide Sales by Region
  9. 3.4.1 Global Liraglutide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Liraglutide Sales by Region (2021-2026)
  11. 3.4.3 Global Liraglutide Sales by Region (2027-2032)
  12. 3.4.4 Global Liraglutide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Liraglutide Revenue by Manufacturers
  2. 4.1.1 Global Liraglutide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Liraglutide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Liraglutide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liraglutide Sales by Manufacturers
  6. 4.2.1 Global Liraglutide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Liraglutide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Liraglutide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Liraglutide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Liraglutide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Liraglutide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Liraglutide Manufacturers, Product Type & Application
  13. 4.7 Global Liraglutide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Liraglutide Market CR5 and HHI
  16. 4.8.2 2025 Liraglutide Tier 1, Tier 2, and Tier 3
5 Liraglutide Market by Type
  1. 5.1 Global Liraglutide Revenue by Type
  2. 5.1.1 Global Liraglutide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Liraglutide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Liraglutide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Liraglutide Sales by Type
  6. 5.2.1 Global Liraglutide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liraglutide Sales by Type (2021-2032) & (K MT)
  8. 5.2.3 Global Liraglutide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Liraglutide Price by Type
6 Liraglutide Market by Application
  1. 6.1 Global Liraglutide Revenue by Application
  2. 6.1.1 Global Liraglutide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Liraglutide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Liraglutide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Liraglutide Sales by Application
  6. 6.2.1 Global Liraglutide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Liraglutide Sales by Application (2021-2032) & (K MT)
  8. 6.2.3 Global Liraglutide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Liraglutide Price by Application
7 Company Profiles
  1. 7.1 HEC Pharm
  2. 7.1.1 HEC Pharm Company Information
  3. 7.1.2 HEC Pharm Business Overview
  4. 7.1.3 HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 HEC Pharm Liraglutide Product Portfolio
  6. 7.1.5 HEC Pharm Recent Developments
  7. 7.2 Bachem
  8. 7.2.1 Bachem Company Information
  9. 7.2.2 Bachem Business Overview
  10. 7.2.3 Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bachem Liraglutide Product Portfolio
  12. 7.2.5 Bachem Recent Developments
  13. 7.3 Bharat Pharmaceuticals
  14. 7.3.1 Bharat Pharmaceuticals Company Information
  15. 7.3.2 Bharat Pharmaceuticals Business Overview
  16. 7.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bharat Pharmaceuticals Liraglutide Product Portfolio
  18. 7.3.5 Bharat Pharmaceuticals Recent Developments
  19. 7.4 Kingpep Biotechnology
  20. 7.4.1 Kingpep Biotechnology Company Information
  21. 7.4.2 Kingpep Biotechnology Business Overview
  22. 7.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Kingpep Biotechnology Liraglutide Product Portfolio
  24. 7.4.5 Kingpep Biotechnology Recent Developments
  25. 7.5 Shenzhen JYMed Technology
  26. 7.5.1 Shenzhen JYMed Technology Company Information
  27. 7.5.2 Shenzhen JYMed Technology Business Overview
  28. 7.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shenzhen JYMed Technology Liraglutide Product Portfolio
  30. 7.5.5 Shenzhen JYMed Technology Recent Developments
  31. 7.6 Wuxi Asiapeptide
  32. 7.6.1 Wuxi Asiapeptide Company Information
  33. 7.6.2 Wuxi Asiapeptide Business Overview
  34. 7.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Wuxi Asiapeptide Liraglutide Product Portfolio
  36. 7.6.5 Wuxi Asiapeptide Recent Developments
  37. 7.7 AmbioPharm
  38. 7.7.1 AmbioPharm Company Information
  39. 7.7.2 AmbioPharm Business Overview
  40. 7.7.3 AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AmbioPharm Liraglutide Product Portfolio
  42. 7.7.5 AmbioPharm Recent Developments
8 North America
  1. 8.1 North America Liraglutide Market Size by Type
  2. 8.1.1 North America Liraglutide Revenue by Type (2021-2032)
  3. 8.1.2 North America Liraglutide Sales by Type (2021-2032)
  4. 8.1.3 North America Liraglutide Price by Type (2021-2032)
  5. 8.2 North America Liraglutide Market Size by Application
  6. 8.2.1 North America Liraglutide Revenue by Application (2021-2032)
  7. 8.2.2 North America Liraglutide Sales by Application (2021-2032)
  8. 8.2.3 North America Liraglutide Price by Application (2021-2032)
  9. 8.3 North America Liraglutide Market Size by Country
  10. 8.3.1 North America Liraglutide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Liraglutide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Liraglutide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Liraglutide Market Size by Type
  2. 9.1.1 Europe Liraglutide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Liraglutide Sales by Type (2021-2032)
  4. 9.1.3 Europe Liraglutide Price by Type (2021-2032)
  5. 9.2 Europe Liraglutide Market Size by Application
  6. 9.2.1 Europe Liraglutide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Liraglutide Sales by Application (2021-2032)
  8. 9.2.3 Europe Liraglutide Price by Application (2021-2032)
  9. 9.3 Europe Liraglutide Market Size by Country
  10. 9.3.1 Europe Liraglutide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Liraglutide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Liraglutide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Liraglutide Market Size by Type
  2. 10.1.1 China Liraglutide Revenue by Type (2021-2032)
  3. 10.1.2 China Liraglutide Sales by Type (2021-2032)
  4. 10.1.3 China Liraglutide Price by Type (2021-2032)
  5. 10.2 China Liraglutide Market Size by Application
  6. 10.2.1 China Liraglutide Revenue by Application (2021-2032)
  7. 10.2.2 China Liraglutide Sales by Application (2021-2032)
  8. 10.2.3 China Liraglutide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liraglutide Market Size by Type
  2. 11.1.1 Asia Liraglutide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Liraglutide Sales by Type (2021-2032)
  4. 11.1.3 Asia Liraglutide Price by Type (2021-2032)
  5. 11.2 Asia Liraglutide Market Size by Application
  6. 11.2.1 Asia Liraglutide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Liraglutide Sales by Application (2021-2032)
  8. 11.2.3 Asia Liraglutide Price by Application (2021-2032)
  9. 11.3 Asia Liraglutide Market Size by Country
  10. 11.3.1 Asia Liraglutide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Liraglutide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Liraglutide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liraglutide Market Size by Type
  2. 12.1.1 SAMEA Liraglutide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Liraglutide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Liraglutide Price by Type (2021-2032)
  5. 12.2 SAMEA Liraglutide Market Size by Application
  6. 12.2.1 SAMEA Liraglutide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Liraglutide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Liraglutide Price by Application (2021-2032)
  9. 12.3 SAMEA Liraglutide Market Size by Country
  10. 12.3.1 SAMEA Liraglutide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Liraglutide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Liraglutide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Liraglutide Value Chain Analysis
  2. 13.1.1 Liraglutide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Liraglutide Production Mode & Process
  6. 13.2 Liraglutide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Liraglutide Distributors
  9. 13.2.3 Liraglutide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst